Lutrate^® Depot 3.75 mg

Leuprolide Acetate

Lutrate^® Depot 3.75 mg is a proprietary depot formulation of Leuprolide Acetate, an LHRH agonist, used every month for three months for pallitative treatment of advanced prostate cancer. The product is based on a patented formulation.

Lutrate^® Depot 22.5 mg

Leuprolide Acetate

Lutrate^® Depot 22.5 mg is a proprietary depot formulation of Leuprolide Acetate, an LHRH agonist, used once in 3 month for pallitative treatment of advanced prostate cancer. The product is based on patented formulation.

  Awaiting DCGI approval

For more information on Lutrate^®
Please refer http://gp-pharm.com/en/products or
Contact your local sales representative or
Email us at info@sayretherapeutics.com

Leuprolide Acetate(Lutrate)

GP pharm with its patented microsphere technology manufactures Leuprolide Acetate or Lutrate for the treatment of prostate cancer. It is available in the following two dosages: 3.75 mg and 22.5 mg.